ArticleCancer immunology, immunotherapy : CII2025

MS275 induces tumor immunosuppression by upregulating PD-L1 and enhances the efficacy of anti-PD-1 immunotherapy in colorectal cancer.

Deng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.